Active Motif Incorporated Licenses Targeted Transposition to Diagenode S.A. Technology

CARLSBAD, Calif., July 31, 2022 /PRNewswire/ — Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precision medicine, announced that it has non-exclusively licensed its foundational patents in transposition for use in CUT&Tag epigenetic assays…

Click here to view original post